Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism

Critical Care Medicine

Volumn 34, Issue 10, 2006, Pages 2624-2629

  Buras, Jon A ^a   Holt, Douglas ^a   Orlow, Daniel ^a   Belikoff, Bryan ^a   Pavlides, Stavros ^a   Reenstra, Wende R ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cecal ligation and puncture; Cytokine; Hyperbaric oxygen; Infection; Interleukin 10; Macrophage; Sepsis

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATION; CECUM; CYTOKINE RELEASE; HOMOGENATE; HYPERBARIC OXYGEN; LIGATION; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEAL FLUID; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; SEPSIS; SPLEEN; SURVIVAL;

ANIMALS; COLONY COUNT, MICROBIAL; HYPERBARIC OXYGENATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; SEPSIS; SURVIVAL ANALYSIS;

EID: 33748776288     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000239438.22758.E0     Document Type: Article

References (36)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Brun-Buisson C, Doyon F, Carlet J, et al: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274:968-974
3. Sitkovsky MV, Ohta A: The 'danger' sensors that STOP the immune response: The A2 adenosine receptors? Trends Immunol 2005; 26:299-304
4. National Institute of Allergy and Infectious Diseases: Excess oxygen worsens lung inflammation in mice. NIH News 2005; May 2
5. Tibbles PM, Edelsberg JS: Hyperbaric-oxygen therapy. N Engl J Med 1996; 334:1642-1648
6. Ross RM, McAllister TA: Protective action of hyperbaric oxygen in mice with pneumococcal septicaemia. Lancet 1965; 191:579-581
7. Thom SR, Lauermann MW, Hart GB: Intermittent hyperbaric oxygen therapy for reduction of mortality in experimental polymicrobial sepsis. J Infect Dis 1986; 154:504-510
8. Zamboni WA, Mazolewski PJ, Erdmann D, et al: Evaluation of penicillin and hyperbaric oxygen in the treatment of streptococcal myositis. Ann Plast Surg 1997; 39:131-136
9. Iazzetti PE, Terzi RGG, Gernandes GA, et al: HOT in sepsis: Bacteriologic patterns and immunologic effects. Undersea Hyperb Med 1998; 25(Suppl):51
10. Oztas E, Kilic A, Ozyurt M, et al: Effect of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb Med 2001; 28:181-186
11. Oter S, Edremitlioglu M, Korkmaz A, et al: Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats. Intensive Care Med 2005; 31:1262-1268
12. Slifka MK, Whitton JL: Clinical implications of dysregulated cytokine production. J Mol Med 2000; 78:74-80
13. Rodriguez JL, Miller CG, Garner WL, et al: Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993; 34:684-694; discussion, 694-695
14. van der Poll T, Marchant A, Buurman WA, et al: Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995; 155:5397-5401
15. Latifi SQ, O'Riordan MA, Levine AD: Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 2002; 70:4441-4446
16. Manley MO, O'Riordan MA, Levine AD, et al: Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 2005; 23:521-526
17. + regulatory T cells in hyperbaric oxygen-mediated immune nonresponsiveness. Hum Immunol 2000; 61:1320-1331
18. Buras JA, Holzmann B, Sitkovsky M: Animal models of sepsis: Setting the stage. Nat Rev Drug Discov 2005; 4:854-865
19. Mader JT, Guckian JC, Glass DL, et al: Therapy with hyperbaric oxygen for experimental osteomyelitis due to Staphylococcus aureus in rabbits. J Infect Dis 1978; 138:312-318
20. Baker CC, Chaudry IH, Gaines HO, et al: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94:331-335
21. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: A review of laboratory models and a proposal. J Surg Res 1980; 29:189-201
22. Shinomiya N, Suzuki S, Hashimoto A, et al: Effect of hyperbaric oxygen on intercellular adhesion molecule-1 (ICAM-1) expression in murine lung. Aviat Space Environ Med 1998; 69:1-7
23. Hong JP, Kwon H, Chung YK, et al: The effect of hyperbaric oxygen on ischemia-reperfusion injury: An experimental study in a rat musculocutaneous flap. Ann Plast Surg 2003; 51:478-487
24. Buras JA, Stahl GL, Svoboda KK, et al: Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: The role of NOS. Am J Physiol Cell Physiol 2000; 278:C292-C302
25. Korhonen K: Hyperbaric oxygen therapy in acute necrotizing infections: With a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol 2000; 89(Suppl 214):7-36
26. Siddiqui A, Davidson JD, Mustoe TA: Ischemic tissue oxygen capacitance after hyperbaric oxygen therapy: A new physiologic concept. Plast Reconstr Surg 1997; 99:148-155
27. Korhonen K, Kuttila K, Niinikoski J: Tissue gas tensions in patients with necrotising fasciitis and healthy controls during treatment with hyperbaric oxygen: A clinical study. Eur J Surg 2000; 166:530-534
28. Echtenacher B, Weigl K, Lehn N, et al: Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect Immun 2001; 69:3550-3555
29. Walley KR, Lukacs NW, Standiford TJ, et al: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996; 64:4733-4738
30. Ebong S, Call D, Nemzek J, et al: Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 1999; 67:6603-6610
31. Oberholzer A, Oberholzer C, Bahjat KS, et al: Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells. J Immunol 2002; 168:3412-3418
32. Benson RM, Minter LM, Osborne BA, et al: Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol 2003; 134:57-62
33. Lahat N, Bitterman H, Yaniv N, et al: Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clin Exp Immunol 1995; 102:655-659
34. Inamoto Y, Okuno F, Saito K, et al: Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun 1991; 179:886-891
35. Grunenfelder J, Miniati DN, Murata S, et al: Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts. J Heart Lung Transplant 2002; 21:244-250
36. Song GY, Chung CS, Chaudry IH, et al: What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant? Surgery 1999; 126:378-383